ADAM17 and metabolic dysfunction-associated steatohepatitis: In NASH mice, MERTK cleavage by ADAM metallopeptidase domain 17 (ADAM17) in liver macrophages decreases during the MASLD-to-MASH transition, and mice with a cleavage-resistant MERTK mutant have increased MASH fibrosis [61].